Crescent BDC Posts $0.37 NII, NAV Slips to $17.72; Authorizes $50M Buyback
CCAP is trading near its 52-week low of $8.395 (10% above the low).
Summary
Crescent BDC earned $0.37 per share in Q3 2026, covering its $0.34 dividend, while NAV per share declined to $17.72 from $19.10 at year-end. The Board authorized a $50 million buyback and Sun Life plans to buy up to $25 million more in the open market.
Key Events · Earnings and Guidance · CCAP
-
Q3 NII Covers Dividend
Net investment income was $0.37 per share versus a $0.34 regular quarterly distribution; total investment income rose to $36.9 million from $36.3 million in Q2.
-
NAV Per Share Falls to $17.72
NAV per share declined to $17.72 at September 30, 2026 from $19.10 at December 31, 2025, and the nine-month net decrease in net assets from operations was $8.6 million versus a $26.0 million increase a year earlier.
-
$50M Buyback Authorized
On November 5, 2026 the Board authorized repurchases of up to $50 million of common stock through an independent broker under a Rule 10b5-1 plan.
-
Sun Life to Buy Up to $25M
Sun Life plans to purchase up to an additional $25 million of common stock in the open market through an independent third-party broker under a Rule 10b5-1 plan.
Analysis · CCAP · Unknown
Q3 net investment income of $0.37 per share covers the $0.34 base dividend, but NAV per share fell to $17.72 from $19.10 at year-end 2025 and the nine-month net result swung to a $8.6 million decrease from operations. Against that backdrop the Board authorized a $50 million repurchase program on November 5, 2026 and Sun Life plans to buy up to an additional $25 million in the open market — together roughly $75 million of potential demand for a company with a $340 million market cap, which is meaningful support for a stock trading well below its NAV. The trade-off: buybacks at a discount to NAV are accretive to remaining holders, but they compete for capital with debt reduction at 1.36x net debt-to-equity.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CCAP was trading at $9.24 on NASDAQ in the Unknown sector, with a market capitalization of approximately $340.5M. The 52-week trading range was $8.40 to $15.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.